Procept BioRobotics [PRCT] vs Bio-Rad Laboratories [BIO] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Procept BioRobotics wins in 4 metrics, Bio-Rad Laboratories wins in 14 metrics, with 0 ties. Bio-Rad Laboratories appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricProcept BioRoboticsBio-Rad LaboratoriesBetter
P/E Ratio (TTM)-27.5023.81Procept BioRobotics
Price-to-Book Ratio6.841.00Bio-Rad Laboratories
Debt-to-Equity Ratio21.0219.73Bio-Rad Laboratories
PEG Ratio-36.1822.69Procept BioRobotics
EV/EBITDA-26.7217.51Procept BioRobotics
Profit Margin (TTM)-36.20%12.50%Bio-Rad Laboratories
Operating Margin (TTM)-39.67%12.19%Bio-Rad Laboratories
EBITDA Margin (TTM)N/A12.19%N/A
Return on Equity-27.62%4.59%Bio-Rad Laboratories
Return on Assets (TTM)-13.36%1.59%Bio-Rad Laboratories
Free Cash Flow (TTM)$-103.62M$266.20MBio-Rad Laboratories
Dividend Yield0.64%N/AN/A
1-Year Return-25.26%-18.45%Bio-Rad Laboratories
Price-to-Sales Ratio (TTM)10.692.79Bio-Rad Laboratories
Enterprise Value$2.43B$7.19BBio-Rad Laboratories
EV/Revenue Ratio9.752.81Bio-Rad Laboratories
Gross Profit Margin (TTM)63.85%52.99%Procept BioRobotics
Revenue per Share (TTM)$5$92Bio-Rad Laboratories
Earnings per Share (Diluted)$-1.69$11.10Bio-Rad Laboratories
Beta (Stock Volatility)1.040.91Bio-Rad Laboratories
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends

Procept BioRobotics vs Bio-Rad Laboratories Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Procept BioRobotics-3.07%-18.39%-30.51%-25.46%-43.09%-52.39%
Bio-Rad Laboratories-0.39%9.63%7.37%14.07%-22.47%-18.67%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Procept BioRobotics-25.26%4.46%14.23%14.23%14.23%14.23%
Bio-Rad Laboratories-18.45%-51.66%-47.62%81.37%212.59%366.92%

Performance & Financial Health Analysis: Procept BioRobotics vs Bio-Rad Laboratories

MetricPRCTBIO
Market Information
Market Cap i$2.66B$7.12B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i1,476,630421,200
90 Day Avg. Volume i1,040,502317,847
Last Close$38.38$264.21
52 Week Range$37.12 - $103.81$211.43 - $387.99
% from 52W High-63.03%-31.90%
All-Time High$103.81 (Nov 11, 2024)$832.70 (Aug 30, 2021)
% from All-Time High-63.03%-68.27%
Growth Metrics
Quarterly Revenue Growth0.55%0.02%
Quarterly Earnings Growth0.55%0.02%
Financial Health
Profit Margin (TTM) i-0.36%0.13%
Operating Margin (TTM) i-0.40%0.12%
Return on Equity (TTM) i-0.28%0.05%
Debt to Equity (MRQ) i21.0219.73
Cash & Liquidity
Book Value per Share (MRQ)$7.04$263.42
Cash per Share (MRQ)$5.72$50.76
Operating Cash Flow (TTM) i$-83,907,000$534.20M
Levered Free Cash Flow (TTM) i$-58,771,876$223.40M
Dividends
Last 12-Month Dividend Yield i0.64%N/A
Last 12-Month Dividend i$0.38N/A

Valuation & Enterprise Metrics Analysis: Procept BioRobotics vs Bio-Rad Laboratories

MetricPRCTBIO
Price Ratios
P/E Ratio (TTM) i-27.5023.81
Forward P/E i-36.1822.69
PEG Ratio i-36.1822.69
Price to Sales (TTM) i10.692.79
Price to Book (MRQ) i6.841.00
Market Capitalization
Market Capitalization i$2.66B$7.12B
Enterprise Value i$2.43B$7.19B
Enterprise Value Metrics
Enterprise to Revenue i9.752.81
Enterprise to EBITDA i-26.7217.51
Risk & Other Metrics
Beta i1.040.91
Book Value per Share (MRQ) i$7.04$263.42

Financial Statements Comparison: Procept BioRobotics vs Bio-Rad Laboratories

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)PRCTBIO
Revenue/Sales i$69.16M$585.40M
Cost of Goods Sold i$25.00M$279.40M
Gross Profit i$44.16M$306.00M
Research & Development i$16.40M$73.50M
Operating Income (EBIT) i$-27.44M$23.70M
EBITDA i$-22.39M$98.50M
Pre-Tax Income i$-24.74M$83.40M
Income Tax iN/A$19.40M
Net Income (Profit) i$-24.74M$64.00M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)PRCTBIO
Cash & Equivalents i$316.21M$521.40M
Total Current Assets i$465.79M$3.04B
Total Current Liabilities i$52.06M$506.60M
Long-Term Debt i$77.83M$1.33B
Total Shareholders Equity i$389.16M$6.68B
Retained Earnings i$-570.72M$7.48B
Property, Plant & Equipment i$21.26M$681.70M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)PRCTBIO
Operating Cash Flow i$-11.65M$156.00M
Capital Expenditures i$-1.84M$-34.40M
Free Cash Flow i$-18.82M$95.50M
Debt Repayment iN/A$-100,000
Common Stock Repurchase iN/A$-101.90M

Short Interest & Institutional Ownership Analysis

MetricPRCTBIO
Shares Short i6.82M894,308
Short Ratio i9.532.47
Short % of Float i0.15%0.05%
Average Daily Volume (10 Day) i1,476,630421,200
Average Daily Volume (90 Day) i1,040,502317,847
Shares Outstanding i54.72M28.01M
Float Shares i53.21M18.51M
% Held by Insiders i0.04%0.16%
% Held by Institutions i0.94%0.93%

Dividend Analysis & Yield Comparison: Procept BioRobotics vs Bio-Rad Laboratories

MetricPRCTBIO
Last 12-Month Dividend i$0.38N/A
Last 12-Month Dividend Yield i0.64%N/A
3-Year Avg Annual Dividend i$0.53N/A
3-Year Avg Dividend Yield i0.12%N/A
3-Year Total Dividends i$1.59N/A
Ex-Dividend DateMar 31, 2025N/A